Scott Randal W. 4
4 · BridgeBio Pharma, Inc. · Filed Sep 7, 2023
Insider Transaction Report
Form 4
Scott Randal W.
Director
Transactions
- Sale
Common Stock
2023-09-05$30.00/sh−2,500$75,000→ 13,500 total(indirect: See Footnote)
Holdings
- 5,000
Common Stock
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by Thinking Bench Capital LLC on June 6, 2023.
- [F2]By Thinking Bench Capital LLC.